DSG3 and acquired polycythemia vera: Ellebrecht et al. conducted a study that armed T lymphocytes with desmoglein (Dsg) 3 CAAR to target cells expressing anti-Dsg3 B cell receptors (BCRs), which are responsible for pemphigus vulgaris (PV) (Figure 2B).